Boron containing compounds as protease inhibitors R Smoum, A Rubinstein, VM Dembitsky, M Srebnik Chemical reviews 112 (7), 4156-4220, 2012 | 438 | 2012 |
In Vitro Evaluation of Calcium Pectinate: A Potential Colon-Specific Drug Delivery Carrier A Rubinstein, R Radai, M Ezra, S Pathak, JS Rokem Pharmaceutical research 10, 258-263, 1993 | 367 | 1993 |
Approaches and opportunities in colon-specific drug delivery A Rubinstein Critical Reviews™ in Therapeutic Drug Carrier Systems 12 (2-3), 1995 | 252 | 1995 |
Microbially controlled drug delivery to the colon A Rubinstein Biopharmaceutics & drug disposition 11 (6), 465-475, 1990 | 221 | 1990 |
Chondroitin sulfate: a potential biodegradable carrier for colon-specific drug delivery A Rubinstein, D Nakar, A Sintov International journal of pharmaceutics 84 (2), 141-150, 1992 | 179 | 1992 |
Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes TT Jubeh, Y Barenholz, A Rubinstein Pharmaceutical research 21, 447-453, 2004 | 169 | 2004 |
Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content A Rubinstein, D Nakar, A Sintov Pharmaceutical research 9, 276-278, 1992 | 163 | 1992 |
Phosphated crosslinked guar for colon-specific drug delivery: I. Preparation and physicochemical characterization I Gliko-Kabir, B Yagen, A Penhasi, A Rubinstein Journal of controlled release 63 (1-2), 121-127, 2000 | 162 | 2000 |
Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa B Tirosh, N Khatib, Y Barenholz, A Nissan, A Rubinstein Molecular pharmaceutics 6 (4), 1083-1091, 2009 | 155 | 2009 |
Phosphated crosslinked guar for colon-specific drug delivery: II. In vitro and in vivo evaluation in the rat I Gliko-Kabir, B Yagen, M Baluom, A Rubinstein Journal of controlled release 63 (1-2), 129-134, 2000 | 152 | 2000 |
The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools A Rubinstein, B Tirosh, M Baluom, T Nassar, A David, R Radai, ... Journal of controlled release 46 (1-2), 59-73, 1997 | 150 | 1997 |
Specific delivery to the gastrointestinal tract A Rubinstein, DR Friend polymeric site-specific Pharmacotherapy, Wiley, Chichester, 282-283, 1994 | 139 | 1994 |
Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT–PNA molecular beacons Y Kam, A Rubinstein, S Naik, I Djavsarov, D Halle, I Ariel, AO Gure, ... Cancer letters 352 (1), 90-96, 2014 | 133 | 2014 |
Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer–doxorubicin conjugates to human colon cancer cells A David, P Kopečková, T Minko, A Rubinstein, J Kopeček European journal of cancer 40 (1), 148-157, 2004 | 133 | 2004 |
Low swelling, crosslinked guar and its potential use as colon-specific drug carrier I Gliko-Kabir, B Yagen, A Penhasi, A Rubinstein Pharmaceutical research 15, 1019-1025, 1998 | 131 | 1998 |
Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat AK Azab, V Doviner, B Orkin, J Kleinstern, M Srebnik, A Nissan, ... Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2007 | 127 | 2007 |
In vitro and in vivo analysis of colon specificity of calcium pectinate formulations A Rubinstein, R Radai European journal of pharmaceutics and biopharmaceutics 41 (5), 291-295, 1995 | 124 | 1995 |
Controlled release oral drug delivery system A Rubinstein, R Radai, M Friedman, B Tirosh, M Baluom, T Nassar US Patent 6,692,766, 2004 | 120 | 2004 |
Gastric emptying of nondigestible solids in the fasted dog P Gruber, A Rubinstein, VHK Li, P Bass, JR Robinson Journal of pharmaceutical sciences 76 (2), 117-122, 1987 | 120 | 1987 |
The colon as a possible target for orally administered peptide and protein drugs SM Haupt, A Rubinstein Critical Reviews™ in Therapeutic Drug Carrier Systems 19 (6), 2002 | 117 | 2002 |